Caricamento...
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
The angiotensin II type 1 (AT(1)) receptor blocker (ARB) candesartan strongly reduces blood pressure (BP) in patients with hypertension and has been shown to have cardioprotective effects. A new ARB, azilsartan, was recently approved and has been shown to provide a more potent 24-h sustained antihyp...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3951115/ https://ncbi.nlm.nih.gov/pubmed/23034464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.147 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|